Ecto-5'-nucleotidase (CD73) Decreases Mortality and Organ Injury in Sepsis
Overview
Authors
Affiliations
The extracellular concentrations of adenosine are increased during sepsis, and adenosine receptors regulate the host's response to sepsis. In this study, we investigated the role of the adenosine-generating ectoenzyme, ecto-5'-nucleotidase (CD73), in regulating immune and organ function during sepsis. Polymicrobial sepsis was induced by subjecting CD73 knockout (KO) and wild type (WT) mice to cecal ligation and puncture. CD73 KO mice showed increased mortality in comparison with WT mice, which was associated with increased bacterial counts and elevated inflammatory cytokine and chemokine concentrations in the blood and peritoneum. CD73 deficiency promoted lung injury, as indicated by increased myeloperoxidase activity and neutrophil infiltration, and elevated pulmonary cytokine levels. CD73 KO mice had increased apoptosis in the thymus, as evidenced by increased cleavage of caspase-3 and poly(ADP-ribose) polymerase and increased activation of NF-κB. Septic CD73 KO mice had higher blood urea nitrogen levels and increased cytokine levels in the kidney, indicating increased renal dysfunction. The increased kidney injury of CD73 KO mice was associated with augmented activation of p38 MAPK and decreased phosphorylation of Akt. Pharmacological inactivation of CD73 in WT mice using α, β-methylene ADP augmented cytokine levels in the blood and peritoneal lavage fluid. These findings suggest that CD73-derived adenosine may be beneficial in sepsis.
Altered CD73-Adenosine Signaling Linked to Infection in Patients undergoing hemodialysis.
Xiang F, Zhang Z, Nie Y, Cao X, Li Y, Chen X J Inflamm Res. 2025; 18:1267-1279.
PMID: 39897527 PMC: 11784357. DOI: 10.2147/JIR.S498575.
CD73 deficiency does not aggravate angiotensin II-induced aortic inflammation in mice.
Massold T, Ibrahim F, Niemann V, Steckel B, Becker K, Schrader J Sci Rep. 2023; 13(1):17125.
PMID: 37816827 PMC: 10564884. DOI: 10.1038/s41598-023-44361-7.
Adenosine metabolized from extracellular ATP ameliorates organ injury by triggering AR signaling.
Kelestemur T, Nemeth Z, Pacher P, Beesley J, Robson S, Eltzschig H Respir Res. 2023; 24(1):186.
PMID: 37438813 PMC: 10339538. DOI: 10.1186/s12931-023-02486-3.
ATPergic signaling disruption in human sepsis as a potential source of biomarkers for clinical use.
Leite R, de Souza P, Haas C, da Silveira F, Mohr K, Bertoni A Clin Exp Med. 2023; 23(7):3651-3662.
PMID: 36943594 PMC: 10511658. DOI: 10.1007/s10238-023-01045-w.
Lovaszi M, Nemeth Z, Pacher P, Gause W, Wagener G, Hasko G Purinergic Signal. 2022; 18(3):345-358.
PMID: 35838900 PMC: 9391554. DOI: 10.1007/s11302-022-09884-0.